CODX vs SBAC · rev $3.9M vs P/E 30, rev $693.7M
Co-Diagnostics, Inc. Common Stock (CODX) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported SBAC revenue for 2024-12-31 was $693.7M. Net income was $748.7M. Revenue was up 3.9% from 2024-09-30 to 2024-12-31. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
CODX currently screens at market cap $31.4M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the CODX and SBAC stock pages for the full models.
Not investment advice.